Niterra Leads $10M Growth Funding Round for Imbed Biosciences
Niterra announced its participation in the $10M convertible debt financing for Imbed Biosciences, Inc. (Imbed), a tissue engineering company developing advanced biomaterials for soft-tissue repair.
Learn More